Breaking News
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
March 23, 2019 - Laparoscopy: MedlinePlus Lab Test Information
March 23, 2019 - Shellfish allergies: can they be treated?
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
March 22, 2019 - Certain bacteria and immune factors in vagina may cause or protect against preterm birth
March 22, 2019 - Research identifies guidelines for prioritizing hepatitis C treatment in U.S. prisons
March 22, 2019 - Novel breath test could pave new way to non-invasively measure gut health
March 22, 2019 - Pharmaceutical and personal care products may result in new contaminants in waterways
March 22, 2019 - New model could revolutionize the way researchers investigate spread of pathogens
March 22, 2019 - MSU professor receives NSF CAREER grant for biosensor diagnostics
March 22, 2019 - High-fat, high-sugar diet in mouse mothers causes problems in the hearts of offspring
March 22, 2019 - ACC: Catheter Ablation Does Not Cut Mortality, Stroke in A-Fib
March 22, 2019 - Wiedemann-Rautenstrauch syndrome – Genetics Home Reference
March 22, 2019 - Health insurance is not assurance of healthcare
March 22, 2019 - Supporting “curiosity-driven research” at the Discovery Innovation Awards
March 22, 2019 - Must-Reads Of The Week (Some Flying Below The Radar)
March 22, 2019 - Newly engineered nanoscale protein micelles can be tracked by MRI
March 22, 2019 - New model more effective in predicting risk of opioid overdose than traditional models
March 22, 2019 - Mayo Clinic study identifies potential new drug therapy for liver diseases
March 22, 2019 - Pitt engineers win $550,000 NSF CAREER award to develop new intervention for people with ASD
March 22, 2019 - Early discharge does not increase readmission risk for patients after lung surgery
March 22, 2019 - Creating diverse pool of trained scientists to address Alzheimer’s research needs
Health Highlights: Oct. 30, 2018

Health Highlights: Oct. 30, 2018

image_pdfDownload PDFimage_print

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Infection Control Team Sent to NJ Rehab Facility Where 9 Children Died

Infection control experts are being sent to a New Jersey rehabilitation facility where an adenovirus outbreak has killed nine children, state health officials said Monday.

“A total of 25 pediatric cases have been associated with this outbreak,” at the Wanaque Center for Nursing & Rehabilitation in Haskell. “A staff member at the facility — who has since recovered — also became ill as part of the outbreak,” according to the state health department, NBC News reported.

Adenovirus typically causes cold-like symptoms, but can be fatal in weakened patients. The children at Wanaque have developmental disorders or immune deficiencies.

The infection control experts will also visit other facilities similar to the Wanaque Center, as well as a public hospital where a different type of infection occurred in four premature babies. One of the babies died, NBC News reported.

“The team will visit University Hospital, Wanaque Center for Nursing & Rehabilitation in Haskell, Voorhees Pediatric Facility in Voorhees, and Children’s Specialized Hospital in Toms River and Mountainside,” the health department said.

The team will reinforce basic infection control procedures, Dr. Shereef Elnahal, the state’s health commissioner, told NBC News.

—–

Food Labels May be Required to List Sesame Allergen: FDA

Sesame may become the latest food allergen that has to be listed on labels, the U.S. Food and Drug Administration says.

Currently, eight major food allergens must be declared on labels: eggs, fish, shellfish, tree nuts, peanuts, wheat and soybeans, CNN reported.

“Unfortunately, we’re beginning to see evidence that sesame allergies may be a growing concern in the US,” FDA Commissioner Dr. Scott Gottlieb said Monday. “A handful of studies, for example, suggest that the prevalence of sesame allergies in the U.S. is more than 0.1 percent, on par with allergies to soy and fish.”

The undeclared presence of allergens is a public health issue and one of the main causes of food recalls, according to the FDA.

Research suggests that more than 300,000 Americans have sesame allergy, according to Lisa Gable, CEO of the nonprofit group Food Allergy Research and Education.

“The consensus of both doctors and advocacy groups that support people with food allergies is that sesame is growing into being a national problem and should absolutely be added as one of the allergens to be disclosed on labeling,” she told CNN.

Allergic reactions to sesame vary from person to person and can range from mild to life-threatening, according to the group.

Currently, sesame “could be in an ingredient list under a word like tahini or even under a very generic term like ‘natural flavor,’ so the worry is that it could be something that even a very careful patient or family might not know is in the food,” Dr. Robert Wood, president of the American Academy of Allergy, Asthma and Immunology, told CNN.

The FDA is seeking more information from allergy and food experts “so we can learn more about the prevalence and severity of sesame allergies in the U.S., as well as the prevalence of sesame-containing foods sold in this country. These include foods that, under current regulations, may not be required to disclose sesame as an ingredient.”

“I think there’s enough evidence to suggest that sesame allergy is as common as a lot of the other foods that are already included in the labeling law, if not more common,” Dr. Scott Sicherer, director of the Jaffe Food Allergy Institute and professor of pediatrics at the Icahn School of Medicine at Mount Sinai, told CNN.

“Including it as part of our U.S. labeling laws makes perfect sense to me,” he said.

—–

NIH Halts Stem Cell Trial for Heart Failure Due to Concerns About Fake Data

A clinical trial assessing the use of stem cells to treat heart failure patients has been paused by the U.S. National Heart, Lung, and Blood Institute because it’s based partly on what may be falsified or fabricated data from the laboratory of a Harvard Medical School-affiliated researcher.

The $63-million CONCERT-HF trial will remain on hold while its data and safety monitoring board conducts a review to ensure the trial meets the “the highest standards for participant safety and scientific integrity,” the NHLBI said Monday.

The patients in the study are being notified and the follow-up protocol of the trial will be continued for all patients who have already been treated.

The trial was launched to investigate whether a certain type of cardiac stem cell, either alone or in combination with other stem cells from the bone marrow, is safe and benefits patients with chronic heart failure, who have few treatment options.

Heart failure patients have a low quality of life and about half die within five years of diagnosis, according to NHLBI.

The clinical trial is based on research from a number of laboratories, including that of Harvard-affiliated Brigham and Women’s Hospital heart researcher Piero Anversa. But the university recently announced that a years-long investigation discovered “falsified and/or fabricated data” in 31 papers from Anversa’s laboratory, the Washington Post reported.

Anversa worked at the hospital until 2015. Last year, the hospital reached a $10 million settlement with the Justice Department to settle allegations that fake data was used by Anversa’s laboratory in grant applications for federal funding.

Before working at Brigham and Women’s Hospital, Anversa worked at New York Medical College. The college released a statement saying it launched an investigation after “serious concerns” had been raised about a 17-year-old study, the Post reported.

Last week, the New England Journal of Medicine retracted one Anversa laboratory paper and flagged two others with an “expression of concern,” and is waiting for more information on those two papers.

Before the NHLBI announcement, scientists had called for the study to be stopped.

“I think that the trial should be halted, and they should have an external review,” Darryl Davis, a cardiologist at the University of Ottawa Heart Institute studying how to regenerate heart tissue, told the Post.

“The Anversa data comprised part of the rationale for that trial, and I think we have to understand better what these cells actually can do before we subject the patients to the risk of having an invasive procedure,” Davis said.

Anversa’s lawyer said his client stands by his studies’ findings and that Anversa only learned from the Harvard probe that a longtime colleague who left his lab in 2013 had improperly altered images, the Post reported.

In many cases, those images can be replaced with correct images, and the results will still be valid, according to Anversa, his lawyer said.

“There is nothing wrong with c-kit positive cardiac stem cells, and the trial will answer the questions concerning their efficacy in patients,” Anversa said in an email, the Post reported.

© 2018 HealthDay. All rights reserved.

Posted: October 2018

Tagged with:

About author

Related Articles